Mosaic ImmunoEngineering, Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported net income was USD 0.019612 million compared to net loss of USD 0.929632 million a year ago.
For the six months, net loss was USD 0.379431 million compared to USD 1.69 million a year ago. Basic loss per share from continuing operations was USD 0.05 compared to USD 0.23 a year ago. Diluted loss per share from continuing operations was USD 0.05 compared to USD 0.23 a year ago.